Development of a Hydroxyurea Decision Aid for Parents of Children With Sickle Cell Anemia.

Main|Search|PHGKB






Last Posted: Aug 02, 2018

---

• Development of a Hydroxyurea Decision Aid for Parents of Children With Sickle Cell Anemia.
  Crosby Lori E et al. Journal of pediatric hematology/oncology 2018 Jul
• Genetic, laboratory and clinical risk factors in the development of overt ischemic stroke in children with sickle cell disease.
  Belisário André Rolim et al. Hematology, transfusion and cell therapy 40(2) 166-181
• What Personal Genome Testing Can and Can't Do-The limitations of personal genome service testing 
  M Shermer, Scientific American, August 2018
• Clinical and genetic ancestry profile of a large multi-centre sickle cell disease cohort in Brazil.
  Carneiro-Proietti Anna B F et al. British journal of haematology 2018 Jul
• A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
  Niihara Yutaka et al. The New England journal of medicine 2018 Jul (3) 226-235
• l-Glutamine and the Dawn of Combination Therapy for Sickle Cell Disease.
  Minniti Caterina P et al. The New England journal of medicine 2018 Jul (3) 292-294
• Cancer Scientists Have Ignored African DNA in the Search for Cures
  J Wapner, Newsweek, July 2018
• Adapting medical guidelines to be patient-centered using a patient-driven process for individuals with sickle cell disease and their caregivers.
  Cronin Robert Michael et al. BMC hematology 2018 1812
• Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.
  Nguyen-Khoa Thao et al. Annales de biologie clinique 2018 Jul
• MANAGEMENT OF PATIENTS WITH SICKLE CELL DISEASE IN ORAL SURGERY: Literature Review and Update.
  Prevost Raphaelle et al. Journal of stomatology, oral and maxillofacial surgery 2018 Jun

more